Paul Merkus

Paul Merkus

Auto-generated profile, based on publicly available information

Paul Merkus

Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2013 in International Journal of Audiology
Verified
Journal Article
Closed access
TLThomas Lenarz
Thomas Lenarz
CJChris James
Chris James
DCDomenico Cuda
Domenico Cuda
AOAlec Fitzgerald O’cOnnor
Alec Fitzgerald O’cOnnor
BFBruno Frachet
Bruno Frachet
AUAlain Uziel
Alain Uziel
To investigate the preservation of residual hearing in subjects who received the Nucleus Hybrid L24 cochlear implant. To investigate the performance benefits up to one year post-implantation in terms of speech recognition, sound quality, and quality of life. Prospective, with sequential enrolment and within-subject comparisons. Post-operative performance using a Freedom Hybrid sound processor was compared with that of pre-operative hearing aids. Sixty-six adult hearing-impaired subjects with bilateral severe-to-profound high frequency hearing loss. Group median increase in air-conduction thresholds in the implanted ear for test frequencies 125-1000 Hz was < 15 dB across the population; both immediately and one year post-operatively. Eighty-eight percent of subjects used the Hybrid processor at one year post-op. Sixty-five percent of subjects had significant gain in speech recognition in quiet, and 73% in noise (≥ 20 percentage points/2 dB SNR). Mean SSQ subscale scores were significantly improved (+ 1.2, + 1.3, + 1.8 points, p < 0.001), as was mean HUI3 score (+ 0.117, p < 0.01). Combining residual hearing with CI gave 22-26 %age points mean benefit in speech recognition scores over CI alone (p < 0.01). Useful residual hearing was conserved in 88% of subjects. Speech perception was significantly improved over preoperative hearing aids, as was sound quality and quality of life.

2 October 2006 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
CSC. Smits
C. Smits
PMP. Merkus
P. Merkus
THT. Houtgast
T. Houtgast

31 May 2019 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ECE. A. van Beeck Calkoen
E. A. van Beeck Calkoen
MEM. S. D. Engel
M. S. D. Engel
JKJ. M. van de Kamp
J. M. van de Kamp
HYH. G. Yntema
H. G. Yntema
SGS.T. Goverts
S.T. Goverts
EHErik F. Hensen
Erik F. Hensen
This study aims to evaluate the etiology of pediatric sensorineural hearing loss (SNHL). A total of 423 children with SNHL were evaluated, with the focus on the determination of causative genetic and acquired etiologies of uni- and bilateral SNHL in relation to age at diagnosis and severity of the hearing loss. We found that a stepwise diagnostic approach comprising of imaging, genetic, and/or pediatric evaluation identified a cause for SNHL in 67% of the children. The most common causative finding in children with bilateral SNHL was causative gene variants (26%), and in children with unilateral SNHL, a structural anomaly of the temporal bone (27%). The probability of finding an etiologic diagnosis is significantly higher in children under the age of 1 year and children with profound SNHL. Conclusions: With our stepwise diagnostic approach, we found a diagnostic yield of 67%. Bilateral SNHL often has a genetic cause, whereas in unilateral SNHL structural abnormalities of the labyrinth are the dominant etiologic factor. The diagnostic yield is associated with the age at detection and severity of hearing loss: the highest proportion of causative abnormalities is found in children with a young age at detection or a profound hearing loss. What is Known: • Congenital sensorineural hearing loss is one of the most common congenital disorders • Determination of the cause is important for adequate management and prognosis and may include radiology, serology, and DNA analysis What is New: • Using a stepwise diagnostic approach, causative abnormalities are found in 67% both in uni- and bilateral SNHL, with the highest diagnostic yield in very young children and those suffering from profound hearing loss • Bilateral SNHL often has a genetic cause, whereas in unilateral SNHL structural abnormalities of the labyrinth are the dominant etiologic factor

26 August 2014 in International Journal of Audiology
Verified
Journal Article
Closed access
PDF file
MKMarre W. Kaandorp
Marre W. Kaandorp
CSCas Smits
Cas Smits
PMPaul Merkus
Paul Merkus
SGS. Theo Goverts
S. Theo Goverts
JFJoost M. Festen
Joost M. Festen
Objective: The primary objective of the study was to investigate the feasibility, reliability, and validity of the Dutch digits in noise (DIN) test for measuring speech recognition in hearing aid and cochlear implant users and compare results to the standard sentences-in-noise (SIN) test. Design: The relation between speech reception thresholds for DIN test and SIN test was analysed to determine the validity of the DIN test. As linguistic skills were expected to make different contributions in these tests, their influence was analysed. Study sample: Participants were 12 normal-hearing listeners, 24 hearing aid users, and 24 cochlear implant users. Results: The DIN test was feasible for more participants than the SIN test. Intraclass correlation coefficients showed high reliability. The standard error of measurement was smaller for the DIN test than for the SIN test. DIN test and SIN test were highly correlated (r = 0.95 and r = 0.56 for NH+ HA and CI users respectively). In the regression analysis no significant contribution of basic linguistic skills or personal factors was found. Conclusion: In the assessment of speech recognition in noise of aided hearing-impaired listeners with hearing aids or cochlear implants, the DIN test is a feasible, reliable and valid test.

27 May 2003 in Neurology
Verified
Journal Article
Closed access
PDF file
PMPaul Merkus
Paul Merkus
HGHenk-Jan Guchelaar
Henk-Jan Guchelaar
DBD. Andries Bosch
D. Andries Bosch
FMFrans W.H.M. Merkus
Frans W.H.M. Merkus
It has been suggested that intranasal (IN) drug delivery could be used to administer drugs directly to the brain, bypassing the blood–brain barrier. Conclusive evidence of this proposed route of drug transport has not been observed by IN-IV comparison. In eight neurosurgery patients with a CSF drain, the uptake in CSF and plasma after IN and IV drug administration was compared. No evidence of direct access of the drugs from the nose to the CSF was found.

29 June 2006 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
PMPaul Merkus
Paul Merkus
FEFenna A. Ebbens
Fenna A. Ebbens
BMBarbara Muller
Barbara Muller
WFWytske J. Fokkens
Wytske J. Fokkens